Trial site
Puyang Oilfield General Hospital
- 16running trials
- 9closed trials
The trials here
What the 25 trials at this site are about, from their registry records.
- Conditions
- Stroke8 trials
- COPD6 trials
- Lupus (SLE)2 trials
- Psoriasis2 trials
- Coronary artery disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Follicular lymphoma1 trial
- Heart failure1 trial
- Liver cirrhosis1 trial
- Metastatic breast cancer1 trial
- Psoriatic arthritis1 trial
- and 1 more
- Phase
- Phase 211 trials
- Phase 311 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Not yet recruiting9 trials
- Completed8 trials
- Recruiting4 trials
- Active, not recruiting3 trials
- Terminated1 trial
- Lead sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.8 trials
- Beijing Tiantan Hospital5 trials
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.5 trials
- Beijing Protgen Biotechnology Development Co., Ltd.1 trial
- Capital Medical University1 trial
- and 5 more
Running trials
Recruiting
A Clinical Trial of TQH3906 Capsules in Adult Patients With Moderate to Severe Plaque Psoriasis
Recruiting
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Recruiting
Not yet recruiting
Ongericimab Injection Reducing Recurrence of Ischemic Stroke
Recruiting
Recruiting
Active, not recruiting
Recruiting
Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Not yet recruiting
Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Stroke3 recruiting
- COPD2 recruiting
- Lupus (SLE)2 recruiting
- Psoriasis2 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- Metastatic breast cancer1 recruiting
- Psoriatic arthritis1 recruiting
Closed trials
Completed
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder
Completed
Completed
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites
Completed
Completed
Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5
Terminated
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
Completed
Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke
Completed
ProUrokinase for Mild Ischemic Cerebrovascular Events (PUMICE)
Completed
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Site data: ClinicalTrials.govUpdated 13 Nov 2026